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S U M M A R Y
Background: Current diagnostic tests are inadequate to detect typhoid cases, as well as the chronic carrier
state, the sole reservoir of Salmonella enterica serovar Typhi. The current study was conducted to ﬁnd
new molecular signatures of pathogen/disease to understand the mechanism behind the host–pathogen
interaction in enteric fever.
Methods: Proteomics-based studies were done to determine the expression of differentially expressed
proteins in the plasma of controls, acute typhoid cases, and chronic typhoid carriers. Further,
transcriptome-based analysis using reverse-transcriptase PCR (RT-PCR) was done in controls, acute
typhoid cases, and chronic typhoid carriers.
Results: Results showed the upregulation of proprotein convertase subtilisin, furin, haptoglobin, and
albumin in the plasma of chronic typhoid carriers. The elevation in mRNA expression of four
differentially expressed proteins conﬁrms the changes at the transcriptional level. Further, the increase
in albumin and haptoglobin in chronic typhoid carriers shows their role in free radical generation,
inﬂammation, and monocyte cell signaling.
Conclusion: Through proteomics techniques, this study identiﬁed four proteins in the chronic typhoid
carrier host that may have a role in the disease pathogenesis of enteric fever.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Enteric fever is a serious systemic disease caused by the
bacterium Salmonella enterica serovar Typhi (S. typhi) and other S.
enterica serovars, including Salmonella enterica Paratyphi A, B, and
C.1 These organisms are facultative intracellular pathogens and
cause systemic infections following ingestion of the organism,
colonization of the small intestine, invasion of the gastrointestinal
mucosal surface, and dissemination throughout the body in the
reticuloendothelial system including the liver, spleen, and bone
marrow.3,4 The complete pathogenesis of enteric fever is unknown,
and complications of the disease become more severe when it is
harbored in the gall bladder, resulting in a chronic carrier state
through which the bacteria are disseminated via frequent* Corresponding author. Tel.: +91 542 2307516/2307535;
fax: +91 542 23675287.
E-mail address: singhabhai2000@gmail.com (A. Kumar).
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where clean drinking water is lacking and hygiene standards are
compromised.1 In developed countries, the incidence is lower and
the disease is mainly associated with travel to endemic locations.2
The long-term persistence of S. typhi in carriers explains why
typhoid fever remains endemic in regions of the world with poor
quality drinking water and defective sewage disposal.5
Retrospective studies carried out in endemic regions have
suggested the association of risk factors with carriage. Middle-aged
adults are more likely to become carriers, while children are
usually short-term carriers.3,6 S. typhi carriers are more likely to be
female and suffering from gall bladder problems.7,8 The carrier
state is thought to be related to bacterial bioﬁlm formation on the
surface of a gall stone.9 The pathogenesis of enteric fever remains
to be characterized; the host–pathogen interaction involves many
intracellular events that prevent the identiﬁcation and eradication
of the pathogen by the host.10,11 There is no animal model for S.
typhi and much of our understanding is derived from the
Salmonella typhimurium mouse infection model and cell culture
experiments.11
The identiﬁcation of carriers is the best way to prevent the
spread of the bacterium; however isolation of S. typhi requiresciety for Infectious Diseases. Open access under CC BY-NC-ND license.
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because of the poor sensitivity of the existing methods of isolation.
The test is based on the detection of antibodies against the
Salmonella lipopolysaccharide (LPS) O antigen; ﬂagellar H antigen
is more indicative of past and current Salmonella infection and not
the carrier state.12 The PCR for typhoid has yielded a sensitivity of
>90% using nested primers, but on other hand the DNA from
uncultured and dead bacteria can also be ampliﬁed by PCR,
therefore colony-forming units cannot be speciﬁcally correlated
with the PCR diagnosis. Moreover molecular methods for the
detection of S. typhi are very technically demanding.13
Proteomics-based methods are currently being employed to
increase our understanding of the pathogenesis of enteric fever and
to explore the peripheral signatures of enteric fever.13 The
molecular signature can be of host or bacterial origin, or a
combination of both, produced during the process of infection.13
Biomarkers for intracellular pathogens, such as tuberculosis, have
been developed using proteomics and mass spectrometry.14,15 The
severe acute respiratory syndrome (SARS) protein biomarker has
been identiﬁed using surface-enhanced laser desorption/ioniza-
tion time-of-ﬂight (SELDI-TOF).15 The present study was con-
ducted to investigate the expression of differentially expressed
proteins in asymptomatic chronic typhoid carriers, acute typhoid
cases, and healthy controls. Two-dimensional (2D) gel electropho-
resis and mass spectrometry techniques were used to identify
newer proteins that may provide an insight into the host–pathogen
interactions after Salmonella infection and in further colonization
of the host leading to the chronic typhoid carrier state. A
transcriptomics-based analysis was further conducted to correlate
the changes occurring at the mRNA level translated exponentially
at the protein level. The results of the present study will provide a
better understanding and insight into the mechanism of the
pathogenesis of Salmonella and allow the development of better
diagnostic and therapeutic approaches to enteric fever.
2. Materials and methods
2.1. Materials
Bovine serum albumin (BSA), Tris-base, acrylamide, N,N0-
methylene bisacrylamide, urea, agarose, 3-[(3-cholamidopropyl)di-
methylammonio]-1-propanesulfonate (CHAPS), sodium dodecyl
sulfate (SDS), dithioerythreitol (DTE), dithiothreitol (DTT), bromo-
phenol blue, ethylenediaminetetraacetic acid (EDTA), and protease
inhibitor cocktail were purchased from Sigma–Aldrich, USA.
Bradford reagent was procured from Bio-Rad, USA, and Immobiline
pH gradient strips, Immobiline pH gradient buffer, and cover ﬂuid
were purchased from Bio-Rad, USA. Glycerol, sodium thiosulfate,
potassium ferricyanide, silver nitrate, sodium carbonate, formalde-
hyde, and methanol were procured from Merck Ltd, India. Thiourea,
acetonitrile, acetic acid, ammonium bicarbonate, triﬂuoroacetic acid
(TFA), and other chemicals required for the study were procured
locally from Sisco Research Laboratory, India. MacConkey agar and
deoxycholate citrate agar were from Hi-Media, India, and TGF-b and
IL-10 ELISA kits were from Invitrogen Corp., USA.
2.2. Selection of subjects
The study was designed to collect blood samples from
outpatients admitted to Sir Sundar Lal Hospital, Institute of
Medical Science, Banaras Hindu University, Varanasi. Patients were
examined by an expert clinician, and those with symptoms
resembling enteric fever were directed for routine clinical
laboratory tests, including Typhidot () and culture. Patients were
aged between 16 and 65 years and were of both sexes, i.e., male and
female. The patients’ past clinical histories and treatments werealso recorded. Blood was collected in an anticoagulant-coated vial
by expert clinicians. The controls were selected from healthy
volunteers who were apparently healthy and without any
symptoms of visible disease. Written consent was obtained from
each participant. The study design was approved by the
institutional ethics committee.
2.3. Sample preparation
Blood samples were collected from controls, acute typhoid cases,
and chronic typhoid carriers, through venipuncture, into EDTA-
coated commercially available vials. The samples were processed
immediately for separation of plasma. The Typhidot assay (AB
Diagnopath Pvt Ltd, New Delhi, India) was performed as per the
manufacturer’s instructions and results were later conﬁrmed by
culture and PCR-based methods. The blood of S. typhi-positive
subjects was centrifuged at 250  g for 20 min at 20 8C; platelet-rich
plasma was obtained, which was centrifuged at 1800  g for 10 min
to obtain platelet-free plasma. The plasma was mixed with protease
inhibitor cocktail and stored at 70 8C until further use.
2.4. Estimation of protein content
The protein concentration was measured by Bradford’s
method16 using BSA as standard.
2.5. 2D-polyacrylamide gel electrophoresis (2D-PAGE)
2D-PAGE was performed using the standard procedure.17,18 The
rehydration reaction was done by using equal amounts of protein of
controls and typhoid patients, about 200 mg, and 150 ml commercial
isoelectric focusing rehydration buffer containing 8 M urea, 2%
CHAPS, 0.5% immobilized pH gradient (IPG) buffer, 0.02% bromo-
phenol blue, and 15 mM DTT, along with IPG strip (pH 4–7); the
reaction was performed overnight at room temperature and
isoelectric focusing was performed in a Multiphor II electrophoresis
unit (Bio-Rad) for 14000 volt h (500 V for 30 min, 1000 V for 10 min,
2000 V for 10 min, 5000 V for 10 min, and 8000 V for the remaining
period). IPG strips were equilibrated for 20 min in equilibration
buffer containing 6 M urea, 30% glycerol, 2% SDS, 0.05 M Tris–HCl pH
8.8, and 0.002% bromophenol blue. Second-dimension electropho-
resis was performed using 12.5% resolving polyacrylamide gel. A
broad range of molecular weight markers were run in parallel to the
strips during the second dimension to calculate the molecular
weight of the proteins of interest. The resulting gels were stained
with silver nitrate using the standard procedure.19 In brief, gels were
ﬁxed for 2 h in ﬁxing solution (methanol:acetic acid:water, 50:5:45),
transferred into water for 1 h, sensitized in sodium thiosulfate
(0.02%) for 2 min, rinsed with water, incubated in silver nitrate
(0.1%) for 30 min, and ﬁnally rinsed with water. The protein spots in
the gels were developed in developing solution containing 2%
sodium carbonate and 100 ml of 37% formaldehyde. Removal of the
developer and addition of 1% glacial acetic acid was used to stop the
staining.
2.6. 2D gel analysis
The 2D gels of controls, acute typhoid cases, and chronic
typhoid carriers were compared using ImageMaster 2D Platinum
software. The contrast for background and spots was normalized
for every gel. Each gel was assigned landmarks following spot
matching. The normalized percentage volumes of the spots from
individual gels were compared between groups to calculate the
percentage change in volume in the acute typhoid and chronic
typhoid groups vs. control. The change in percentage volume of
spots in the 2D gels of controls and acute typhoid cases and chronic
Table 1
Details of patients and controls, with clinical laboratory investigations
Control
(Group 1)
Acute
typhoid
(Group 2)
Chronic typhoid
carrier
(Group 3)
Number 50 50 50
Age, months 304  20.12 323  19.42 353  27.18
Sex, % female 50 65 78
Duration of fever, days No fever 6  3.0 12  3.0
Culture test positivity, % Negative 54 36
Typhidot IgG positivity, % Negative 14 66
Typhidot IgM positivity, % Negative 86 10
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change in spot volume were used for further analysis.
2.7. Sample preparation for mass spectrometry
The sample for mass spectrometry was made using the standard
procedure,20 with slight modiﬁcations. In brief, silver-stained spots
found to be differentially expressed were excised, cut into pieces,
and washed with 500 ml water with agitation on a vortex mixer. To
remove silver stains, excised spots were incubated with 250 ml of
50 mM sodium thiosulfate and 15 mM potassium ferricyanide for
5 min and washed twice with 500 ml water to remove reducing
agents. The excised spots were incubated at 60 8C for 30 min with
500 ml of 100 mM NH4HCO3 and 45 mM DTT, followed by cooling;
500 ml of 100 mM iodoacetamide was then added and further
incubation carried out for 30 min in the dark at room temperature.
Excised spots were sliced and equilibrated with 500 ml of 50 mM
ammonium bicarbonate in 50% acetonitrile, dehydrated with 500 ml
of 100% acetonitrile for 20 min, and air-dried. Sliced spots were
rehydrated in 30 ml of a solution containing 0.02 mg/ml trypsin and
50 mM ammonium bicarbonate at 4 8C for 60 min. The supernatant
was discarded and 30–50 ml of 50 mM ammonium bicarbonate was
added to the excised spots; these were incubated at 37 8C for 16–
18 h and the supernatant removed. Twenty-ﬁve to ﬁfty microliters
of 1% TFA in 60% acetonitrile was added to the pellet and this was
sonicated for 10 min. The supernatant was removed following
centrifugation at 12000  g for 30 s. Both the supernatants were
mixed, freeze-dried, and concentrated by centrifugal evaporation to
dryness.
2.8. Matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF) and liquid chromatography mass spectrometry (LC-MS)
Mass spectrometric analysis of samples was done at The Centre
for Genomic Applications (TCGA), New Delhi. In brief, matrix,
namely a-cyano-4-hydroxycinnamic acid (CHCA) matrix, was
mixed with the dissolved trypsinized peptide samples. After
drying, the peptides were spotted on a ground steel plate and
subjected to Bruker Ultraﬂex MALDI-TOF/TOF and 2D Nano LC-ESI-
Trap (Agilent) for mass spectrometric identiﬁcation. The instru-
ment was equipped with a pulsed nitrogen laser.
2.9. Analysis of peptide sequences
Data acquisition and analysis was performed using Flex Control
and Flex Analysis/Biotools version 2.2 software, respectively. Data
were acquired in reﬂectron-positive mode using 15–18% laser
power. The MALDI and tandem spectra used for protein
identiﬁcation from tryptic fragments were searched against the
MASCOT search engine. Mass tolerance and monoisotopic values
(100 ppm for peptide mass ﬁngerprint and peptide mass tolerance
of 2 Da for MS/MS spectra) were used for searching. The
probability-based MOWSE score was calculated in terms of ionTable 2
Temperature and time conditions for the PCRs
h-Hp b-Actin 
Pre-denaturation 95 8C 1 min 95 8C 1 min 
Denaturation 94 8C 40 s 94 8C 30 s 
Primer annealing 55 8C 30 s 55 8C 30 s 
Extension 72 8C 40 s 72 8C 1 min 
Number of cycles 34 30 
Final extension 72 8C for 5 min 72 8C for 5 min 
Cooling 4 8C 4 8C 
h-Hp, human haptoglobin; PC5, proprotein convertase subtilisin.score –10*log (p), where p is the probability and the observed
match was considered a random event. Protein scores were derived
from ions as a non-probabilistic basis for ranking protein hits, and
proteins identiﬁed by MALDI-TOF and LC-MS were of the expected
size based on their position in the gel.
2.10. Reverse-transcriptase PCR (RT-PCR)
RNA was isolated from whole blood using TRIzol reagent.
Polyadenylated RNA was reverse-transcribed using oligo-dT
primers and the RT-PCR was performed using an RT-PCR kit
(Thermo-Scientiﬁc) in accordance with the manufacturer’s proto-
col. The cDNA was synthesized from isolated RNA using RevertAid
Minus Mu-LV Reverse Transcriptase under standard conditions, as
supplied by the manufacturer. The primer sequences used for this
study are given in Table 3. The gene expression of b-actin was
evaluated concurrently with haptoglobin, proprotein convertase
subtilisin (PC5), furin, and albumin. A total 2-ml aliquot of cDNA
was added to a ﬁnal volume of 25 ml of PCR mixture (10 mM Tris
HCl, 50 mM KCl, 1.5 mM MgCl2, 0.5 mM dNTP, 0.4 mM primers, 2.5
U Taq DNA polymerase). The reaction conditions and cycles for
ampliﬁcation of the respective genes are given in Table 2. The PCR
products were visualized using agarose gel electrophoresis. The
band density was analyzed using a computerized densitometry
system (Alpha Imager System, Alpha Innotech Corporation, South
Africa).
2.11. Statistical analysis
The Student’s t-test was used for comparisons between the
different groups; the data are expressed as the mean  standard
error. The differences were considered statistically signiﬁcant when
the p-value was less than 0.05.
3. Results
3.1. Classiﬁcation of subjects
The subjects who underwent a clinical examination and who
had a previous history of enteric fever were subjected to routinePC5 Furin Albumin
95 8C 1 min 95 8C 1 min 94 8C 5 min
95 8C 30 s 95 8C 30 s 94 8C 1 min
60 8C 30 s 60 8C 30 s 62 8C 1 min
72 8C 60 s 72 8C 1 min 72 8C 1 min
40 40 35
72 8C for 5 min 72 8C for 5 min 72 8C for 10 min
4 8C 4 8C 4 8C
Table 3
Sequences of the PCR primers used, PCR product length, and reference source
Gene NIH GenBank accession No. Product length (bp) Primer sequence, 50–30
Haptoglobin NM005143 338 F = CCTGAATGTGAAGCAGTATGTa
R = TTCTGTTTGAGTTTGATGAGCa
b-Actin AY141970 226 F = CGTGGGCCGCCCTAGGCACCA
R = GGGGGCCTCGGTCAGCAGCAC
Proprotein convertase subtilisin NM001190482 109 F = CCTGGAAGAGAGGCTACACG
R = CAACTTGCCAGAGCATCGTA
Furin XM003919409 112 F = GTACAGTGGCTGGAACAGCA
R = GCTGAGTGACACCAGACAGG
Albumin M12523 230 F = GTAATCGGTTGGCAGCCAATG
R = CACTCTTGTGTGCATCTCG
F, forward; R, reverse.
a Nucleotide primer sequence.
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323  19.42 months, 65% female, 27/50 (54%) culture-positive) and
50 chronic typhoid carriers (age 353  27.18 months, 78% female, 18/
50 (36%) culture-positive) were suspected positive for enteric fever
after serological and culture tests. Typhidot IgG positivity was found
in 33/50 (66%) with a history of fever of more than 12  3.0 days and a
past history of typhoid fever; these cases were assigned to the chronic
typhoid carriers group. Typhidot IgM positivity was found in 43/50
(86%) cases with a history of fever of 6  3.0 days and with no past
history of enteric fever; these cases were assigned to the acute
typhoid group. Fifty healthy volunteers aged 304  20.12 months
(50% female) with no signs of any type of disease and found negative
by culture and serological tests were assigned to the control group.
Details of the patient and control groups are given in Table 1.
3.2. 2D gel electrophoresis of plasma proteins in enteric fever patients
The plasma proteins from 50 controls, 50 acute typhoid cases,
and 50 chronic typhoid carriers were subjected to 2D gel
electrophoresis. Each set of experiments was reproduced twice
and the data analyzed by ImageMaster 2D Platinum software.
Figure 1 shows the complete resolution of the proteins on 2D gels.
A percentage volume change of spots for the typhoid groups
greater than two-fold that of the controls was taken into
consideration. The expression of four protein spots was found to
be signiﬁcantly upregulated in chronic typhoid carriers as
compared to controls and acute typhoid cases, however very little
change was observed between the expression of the four spots in
acute typhoid cases as compared to controls. Further, theFigure 1. Complete 2D gel electrophoretogram showing the resolution of plasma prdifferences in expression of all four spots showed a signiﬁcant
upregulation in cases of chronic typhoid carriers as compared to
acute typhoid cases (Figure 2). Mass spectrometric analysis using
MALDI-TOF and LC-MS identiﬁed these proteins as proprotein
convertase subtilisin, furin, haptoglobin, and albumin (Figure 2).
MALDI mass spectra and the probability plot corresponding to
proprotein convertase subtilisin, furin, haptoglobin, and albumin,
provided m/z values for each protein; these were used to search
proteins in the available protein database. With regard to the ion
score (10*log (p), where p is the probability and the observed
match was random), protein scores greater than 33 for proprotein
convertase subtilisin, furin, and haptoglobin, and greater than 34
for albumin, were considered signiﬁcant (p < 0.05). The probabili-
ty-based MOWSE score obtained for albumin was 157 (p < 0.05);
the score was 143 for haptoglobin, 58 for furin, and 38 for
proprotein convertase subtilisin. Details of the peptide summary
report are given in Table 4, as per the minimum information about
proteomics experiment (MIAPE) standard.
3.3. Reverse transcription and expression analysis
Changes found at the protein level in the controls, acute typhoid
cases, and chronic typhoid carriers were further evaluated at the
mRNA level. The expression of proprotein convertase subtilisin,
haptoglobin, and albumin in chronic typhoid carriers was
signiﬁcantly higher compared to those of control and acute
typhoid cases (p < 0.01 and p < 0.01, respectively; Figure 3).
Further, the expression of furin in cases of chronic typhoid was
signiﬁcantly higher as compared with control and acute typhoidoteins isolated from controls, acute typhoid cases, and chronic typhoid carriers.
Figure 2. a 2D gel electrophoretogram of plasma proteins from controls, acute typhoid cases, and chronic typhoid carriers after silver staining. (b) Graphical representation of
the percentage volume changes of spot expression in the control, acute typhoid cases, and chronic typhoid carriers groups; *p < 0.05 for controls vs. chronic typhoid carriers,
and #p < 0.05 for acute typhoid cases vs. chronic typhoid carriers in the case of spot 1 (proprotein convertase subtilisin); *p < 0.05 for controls vs. chronic typhoid carriers, and
#p < 0.05 for acute typhoid cases vs. chronic typhoid carriers in the case of spot 2 (furin); **p < 0.01 for controls vs. chronic typhoid carriers, and ##p < 0.01 for acute typhoid
cases vs. chronic typhoid carriers in the case of spot 3 (haptoglobin); *p < 0.05 for controls vs. chronic typhoid carriers, and #p < 0.05 for acute typhoid cases vs. chronic
typhoid carriers in the case of spot 4 (albumin).
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signiﬁcant changes were observed between the acute typhoid
cases and the control group in the expression analysis of all genes
(Figure 3).
4. Discussion
The diagnosis of S. typhi and S. paratyphi A in chronic typhoid
carriers requires special consideration as they are a silent threat to
others in the population.21,22 There is no gold standard test for the
detection of chronic typhoid carriers, but the least invasive and
most acceptable is stool culture.23 Although molecular methods
such as PCR have been used extensively in the identiﬁcation of
acute typhoid cases, its application in chronic typhoid cases is
limited due to the low level of S. typhi bacteremia in blood.24–26,28
Bacteriological screening of S. typhi carriers is expensive and
logistically difﬁcult to perform, therefore a serological means is ofpractical importance.25,26 In the current study we tried to screen
for S. typhi infection in enteric fever cases using bacteriological
and serological methods and used 2D gel electrophoresis and
mass spectrometry as an alternative method to differentiate
chronic typhoid carriers based on alterations in the expression of
proteins.
When analyzed, the plasma proteome of controls, acute typhoid
cases, and chronic typhoid carriers showed signiﬁcant differences
in the expression of four protein spots. Mass spectrometry data
revealed these spots to be proprotein convertase subtilisin, furin,
haptoglobin, and albumin. Proprotein convertase subtilisin and
furin are enzymes that cause speciﬁc proteolysis in a regulatory
mechanism for the generation of biologically active proteins.27 The
process of activation is performed by subtilisin and/or kexin-
related enzymes known as proprotein convertases (PCs). These
recognize and process precursor proteins at the consensus motif
RXR/RR.29,30
Table 4
Details of the peptide summary reporta
Query Observed Mr(expt) Mr(calc) Delta Miss Score Expect Rank Peptide
P00739 (HPTR_HUMAN)b
385 490.12 978.22 977.50 0.72 0 (38) 0.027 1 K.NPANPVQR.I
386 490.15 978.29 977.50 0.79 0 42 0.012 1 K.HPVDQVQR.I
456 538.17 1074.33 1074.58 0.25 1 3 95 5 R.MLCVRLGAR.N
651 712.57 1423.12 1422.76 0.36 1 (31) 0.1 1 K.NDVTDISDDRFPK.C
652 475.75 1424.24 1422.76 1.48 1 (31) 0.098 1 K.NDVTDISDDRFPK .C
653 475.77 1424.29 1422.76 1.53 1 41 0.0091 1 K.NDVTDISDDRFPK.C
665 485.05 1452.14 1451.70 0.44 1 4 51 10 K.DYVAPGRMLCVR.L + oxidation (M)
784 834.45 1666.88 1666.80 0.08 0 58 0.00018 1 K.LTLYVGKKQLVEIEK.Q
P09958 (FURIN_HUMAN)c
504 319.87 956.60 957.51 0.91 0 3 93 10 K.LLAADAIR.M
698 738.83 1475.64 1474.78 0.86 0 58 0.00022 1 R.TSEANNYGTLTK.W
Q6UW60 (PCSK4_HUMAN)d
319 445.28 444.27 444.23 0.04 0 8 1.5 3 K.GPGSK.N
491 320.13 957.37 958.58 1.21 1 13 7.9 1 K.TAAPALRV.Q
516 337.47 1009.39 1009.41 0.01 0 17 2.9 1 -.MDLPLYAWLSR.C + oxidation (M)
P02768 (ALBUMIN_HUMAN)e
246 712.38 711.37 711.37 0.01 0 (9) 16 2 K.SEIAHR.F
247 356.94 711.86 711.37 0.50 0 31 0.11 1 K.SEVAHR.F
300 805.42 804.41 803.40 1.01 0 3 1.1e+002 2 K.ATEDQLK.T
384 450.17 898.32 897.47 0.85 0 (23) 0.74 1 R.LCVLHEK.T
385 899.37 898.36 897.47 0.89 0 (16) 3.8 9 R.LCVLHEK.T
387 450.32 898.62 897.47 1.15 0 (17) 3.2 3 R.LCVLHEK.T
388 450.43 898.85 897.47 1.38 0 27 0.37 1 R.LCTVATL.T
501 367.10 1098.29 1099.66 1.37 1 9 18 9 K.KQTALAELVK.H
517 558.66 1115.31 1115.65 0.34 1 5 43 6 K.LATDLTKINK.E
685 1479.61 1478.60 1478.79 0.19 0 (0) 1.1e+002 4 K.LGEYGFQNAILVR.Y
686 1479.68 1478.67 1478.79 0.12 0 (24) 0.45 1 K.LGEYKFQNALLVR.Y
687 1479.77 1478.76 1478.79 0.03 0 (16) 2.9 1 K.LGEYKFQNALLVR.Y
688 740.67 1479.32 1478.79 0.53 0 70 1.1e005 1 K.LGEYKFQNALLVR.Y
689 1480.71 1479.70 1478.79 0.91 0 (29) 0.16 1 K.LGEYKFQNALLVR.Y
690 740.87 1479.72 1478.79 0.93 0 (52) 0.00077 1 K.LGEYKFQNALLVR.Y
691 741.39 1480.76 1478.79 1.97 0 (14) 5.6 1 K.LGEYKFQNALLVR.Y
823 941.90 1881.78 1881.93 0.15 0 17 1.8 1 R.RPCFSALEVDETYVPK.E
a Search parameters: Type of search: MS/MS ion search; enzyme: trypsin; ﬁxed modiﬁcations: carbamidomethyl (C); variable modiﬁcations: oxidation (M); mass values:
monoisotopic; protein mass: unrestricted; peptide mass tolerance: 2 Da; fragment mass tolerance: 0.8 Da; max missed cleavages: 1; instrument type: ESI-TRAP.
b P00739 (HPTR_HUMAN), haptoglobin-related protein – human; mass 39020, score 143, query matched 8.
c P09958 (FURIN_HUMAN), furin protein – human; mass 86778, score 58, query matched 2.
d Q6UW60 (PCSK4_HUMAN), proprotein convertase subtilisin/kexin type 4; mass 83115, score 38, query matched 3.
e P02768 (ALBUMIN_HUMAN), albumin; mass 70710, score 157, query matched 18.
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of Gram-negative bacilli and viruses.31 The release of LPS from
Gram-negative bacteria results in the induction of proprotein
convertase subtilisin, which affects the level of lipid and
lipoprotein metabolism through regulation of lipid receptors on
hepatic cells.31 The chronic carrier stage and gall stone formation
are highly associated, because a cholesterol-rich and lithogenic
diet allow bioﬁlm formation.32 In the present study, an increase in
proprotein convertase subtilisin in chronic carriers shows the
involvement of chronic inﬂammation induced by the pathogen in
the host and an alteration in lipid metabolism and lipid
concentration that might lead to gall stone formation. The
formation of gall stones in chronic typhoid carriers and the intake
of a cholesterol-rich diet were observed in most of the chronic
typhoid carriers in our study.
The exploitation of host furin in the activation of bacterial
toxin, allowing entry into the host cell, has also been well
reported.48 Proteolytic processing by furin is an important
determinant of pathogenicity for viruses and bacterial toxins.34
The presence of furin in the trans-Golgi network requires a
minimum recognition motif for the optimal processing of various
bacterial and viral endotoxins in the disease pathogenesis.34 The
cell-speciﬁc type expression of furin is not clear; T-cells
predominantly express furin, which activates T-cell-activated
genes that modulate an important immunosuppressive cyto-
kine.48 The increase in furin expression in our study might have
some role in the induction of immunosuppressive cytokines.
Transforming growth factor beta (TGF-b) upregulates theexpression of the fur gene, which in turn increases pro-TGFb1
maturation.35
The roles of proprotein convertase subtilisin and furin in the
activation of matrix metalloproteinases (MT-MMP), which are
involved in extracellular matrix degradation, are known.33 An
increase in TGF-b upregulates the activity of MT-MMPs, and their
involvement in different types of cancer is well established.33 A
large cohort study of a typhoid outbreak in 1964 showed a
markedly increased risk of gall bladder cancer in chronic carriers –
as high as 167 times that of non-carriers.35 The expression of MT-
MMP in the stromal component may be essential for the malignant
potential of gall bladder cancer.36 The increase in furin and
proprotein convertase subtilisin indicates that after infection with
Salmonella, these proteins may induce the expression of MT-
MMPs, which play an important role in cancer invasiveness in gall
bladder cancer.37
Typhoid fever can cause anemia by a variety of mechanisms.38
In acute infection or hepatic dysfunction, there is usually very little
change in serum albumin levels, because albumin has a long
biological half-life.39,40 The level of albumin was upregulated in
chronic typhoid cases in our study, and this might be due to an
increase in free radicals during Salmonella infection; the release of
hydroxyl radicals and nitric oxide in cases of Salmonella has
already been reported.41,42 The increase in albumin found mainly
in chronic typhoid carriers in the current study might occur in
order to counteract the generation of free radicals, because
albumin is known to have antioxidant properties during free
radical generation in the case of infection.43–45
Figure 3. a Agarose gel electrophoretogram of proprotein convertase subtilisin,
furin, haptoglobin, and albumin on 1.5% agarose gel electrophoresis and the
corresponding b-actin expression in the control, acute typhoid cases, and chronic
typhoid carriers groups, respectively. (b) Graphical representation of the ratio of
gene expression with corresponding b-actin expression; ***p < 0.001 for controls
vs. chronic typhoid carriers, and ##p < 0.01 for acute typhoid cases vs. chronic
typhoid carriers in the case of proprotein convertase subtilisin; *p < 0.05 for
controls vs. chronic typhoid carriers, and #p < 0.05 for acute typhoid cases vs.
chronic typhoid carriers in the case of furin; **p < 0.01 for controls vs. chronic
typhoid carriers, and ##p < 0.01 for acute typhoid cases vs. chronic typhoid carriers
in the case of haptoglobin; **p < 0.01 for controls vs. chronic typhoid carriers, and
##p < 0.01 for acute typhoid cases vs. chronic typhoid carriers in the case of
albumin.
A. Kumar et al. / International Journal of Infectious Diseases 19 (2014) 59–66 65The antagonistic effect of haptoglobin on endotoxin was ﬁrst
demonstrated by Baseler and Burrell.46 The effect of haptoglobin
on endotoxin-induced cytokine release is not yet known.47
However, it is evident from past research that haptoglobin enters
monocytes and neutrophils and interrupts the intracellular
function triggered by intracellular LPS.47 The role of haptoglobin
in the modulation of proinﬂammatory cytokines and anti-
inﬂammatory cytokines is debatable and needs further investiga-
tion.47 The present study showed an increase in haptoglobin,
which is an acute phase protein, in chronic typhoid carriers, and
this might have a signiﬁcant role in triggering the intracellular
signaling of monocytes and neutrophils during typhoid carriage.
The role of haptoglobin as a modulator of inﬂammation in
pathological conditions such as respiratory infections and en-
dotoxic shock is already known.47 Thus, increased levels of
haptoglobin during typhoid carriage provide the environment
for S. typhi to modulate the release of cytokines during infection
and to sustain its survival in the host. The data from the present
study clearly indicate the role of the proteins identiﬁed in chronic
typhoid carriers, which have a potential effect in perturbing thehost inﬂammatory response triggered by S. typhi during its
carriage. Further, the role of these proteins in the intracellular
cell signaling of monocytes in chronic typhoid carriers needs
further investigation in order to understand the mechanism of the
host–pathogen interaction and to develop diagnostic kits and
therapeutic drug targets.
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